Evidence-based review of treatment options for patients with glottic cancer

Head and Neck

Volumn 33, Issue 11, 2011, Pages 1638-1648

  Hartl, Dana M ^a,b   Ferlito, Alfio ^c   Brasnu, Daniel F ^d   Langendijk, Johannes A ^e   Rinaldo, Alessandra ^c   Silver, Carl E ^f   Wolf, Gregory T ^g  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ SORBONNE NOUVELLE PARIS 3   (France)

^c UNIVERSITY OF UDINE   (Italy)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

chemotherapy; glottic cancer; radiotherapy; surgery; transoral laser

Indexed keywords

CETUXIMAB; CISPLATIN;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; LARYNGECTOMY; LARYNX CARCINOMA; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING;

CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; FEMALE; GLOTTIS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LASER THERAPY; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80052727685     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21528     Document Type: Review

References (121)

1. Elstein AS,. On the origins and development of evidence-based medicine and medical decision making. Inflamm Res 2004; 53 (Suppl 2): S184-S189. (Pubitemid 39149877)
2. Blakley BW, Magit AE,. Letter to the Editor. Response to: Hornibrook J. The role of tonsillectomy in reducing recurrent pharyngitis: a systematic review. Otolaryngol Head Neck Surg 2009; 141: 155-156.
3. Pfister DG, Laurie SA, Weinstein GS, et al. American Society of Clinical Oncology clinical practice guidelines for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006; 24: 3693-3704. (Pubitemid 46630546)
4. Sackett DL,. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989; 95 (Suppl 2): S2-S4.
5. Sobin LH, Wittekind C,. UICC International Union Against Cancer. TNM classification of malignant tumors, 6th edition. New York: Wiley-Liss; 2002. pp 36-42.
6. Hartl DM, Brasnu DF, Fried MP,. Conservation surgery for glottic cancer. In:, Fried MP, Ferlito A, editors. The larynx, 3rd edition. San Diego, CA: Plural Publishing; 2009. pp 515-543.
7. Bron LP, Soldati D, Zouhair A, et al. Treatment of early stage squamous-cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy. Head Neck 2001; 23: 823-829. (Pubitemid 32862285)
8. Ambrosch P,. The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 82-88. (Pubitemid 46594858)
9. 3 glottic cancer: The University of Brescia experience on 595 patients. Head Neck 2009; Nov 9 [Epub ahead of print].
10. 2 laser surgery in the treatment of glottic cancer. Head Neck 2005; 27: 566-574.
11. 2 laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases. Laryngoscope 2009; 112: 370-374.
12. Laccourreye O, Weinstein G, Brasnu D, Trotoux J, Laccourreye H,. Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol 1991; 100: 68-71.
13. Neel HB, Devine KS, Desanto LW,. Laryngofissure and cordectomy for early cordal carcinoma: outcome in 182 patients. Otolaryngol Head Neck Surg 1980; 88: 79-84. (Pubitemid 10176330)
14. Thomas JV, Olsen KS, Neel HB, DeSanto LW, Suman VJ,. Early glottic carcinoma treated with open laryngeal procedures. Arch Otolaryngol Head Neck Surg 1994; 120: 264-268. (Pubitemid 24097726)
15. Brumund KT, Guitierrez-Fonseca R, Garcia D, Babin E, Hans S, Laccourreye O,. Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol 2005; 114: 314-322. (Pubitemid 40529988)
16. Giovanni A, Guelfucci B, Gras R, Yu P, Zanaret M,. Partial frontolateral laryngectomy with epiglottic reconstruction for management of early-stage glottic carcinoma. Laryngoscope 2001; 111: 663-668. (Pubitemid 32295282)
17. Soo KC, Shah JP, Gopinath KS, Gerold FP, Jacques DP, Strong EW,. Analysis of prognostic variables and results after supraglottic partial laryngectomy. Am J Surg 1988; 156: 301-305.
18. Leroux-Robert J,. A statistical study of 620 laryngeal carcinomas of the glottic region personally operated upon more than five years ago. Laryngoscope 1975; 85: 1440-1444.
19. Laccourreye O, Laccourreye L, Garcia D, Guttierrez-Fonseca R, Brasnu D, Weinstein G,. Vertical partial laryngectomy versus supracricoid partial laryngectomy for selected carcinomas of the true vocal cord classified as T2N0. Ann Otol Rhinol Laryngol 2000; 109: 965-971.
20. Bailey BJ, Calcaterra TC,. Vertical subtotal laryngectomy and laryngoplasty. Review of experience. Arch Otolaryngol 1971; 93: 232-237.
21. Biller HF, Lawson W,. Partial laryngectomy for cancer with marked limitation or fixation of the vocal cord. Laryngoscope 1986; 96: 61-64. (Pubitemid 16183415)
22. Daniilidis J, Nicolaou A, Fountzilas G, Sombolos K,. Vertical partial laryngectomy: our results after treating 81 cases of T2 and T3 laryngeal carcinomas. J Laryngol Otol 1992; 106: 349-352.
23. Ogura JH, Sessions DG, Spector GJ,. Analysis of surgical therapy for epidermoid carcinoma of the laryngeal glottis. Laryngoscope 1975; 85: 1522-1530.
24. Tucker HM, Benninger MS, Roberts JK, Wood BJ, Levine HL,. Near-total laryngectomy with epiglottic reconstruction: long-term results. Arch Otolaryngol Head Neck Surg 1989; 115: 1341-1344. (Pubitemid 19277200)
25. Mallet Y, Chevalier D, Darras JA, Wiel E, Desaulty A,. Near total laryngectomy with epiglottic reconstruction. Our experience of 65 cases. Eur Arch Otorhinolaryngol 2001; 258: 488-491. (Pubitemid 33141266)
26. Brasnu DF,. Supracricoid partial laryngectomy with cricohyoidopexy in the management of laryngeal carcinoma. World J Surg 2003; 27: 817-823. (Pubitemid 37022396)
27. Dufour X, Hans S, de Monès E, Brasnu D, Ménard M, Laccourreye O,. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 2004; 130: 1092-1099. (Pubitemid 39195393)
28. Laccourreye O, Brasnu D, Merite-Drancy A, et al. Cricohyoidopexy in selected infrahyoid epiglottic carcinomas presenting with pathological preepiglottic space invasion. Ann Otolaryngol Head Neck Surg 1993; 119: 881-886. (Pubitemid 23232297)
29. Alajmo E, Fini-Storchi O, Agostini V, Polli G,. Conservation surgery for cancer of the larynx in the elderly. Laryngoscope 1985; 95: 203-205. (Pubitemid 15169276)
30. Maurice N, Crampette L, Mondain M, Guerrier B,. Subtotal laryngectomy with cricohyoidopexy: carcinologic results and early functional follow-up. A propos of 49 cases. Ann Otolaryngol Chir Cervicofac 1994; 111: 435-442.
31. Piquet JJ, Chevalier D,. Subtotal laryngectomy with crico-hyoido- epiglottopexy for the treatment of extended glottic carcinomas. Am J Surg 1991; 162: 357-361.
32. Laccourreye O, Weinstein GS, Brasnu D, et al. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2. Cancer 1994; 74: 2781-2790. (Pubitemid 24340544)
33. Marandas P, Hartl DM, Charffedine I, Le Ridant AM, Schwaab G, Luboinski B,. T2 laryngeal carcinoma with impaired mobility: subtypes with therapeutic implications. Eur Arch Otorhinolaryngol 2002; 259: 87-90. (Pubitemid 34185608)
34. Peretti G, Nicolai P, Piazza C, Redaelli de Zinis LO, Valentini S, Antonelli AR,. Oncological results of endoscopic resections of Tis and T1 glottic carcinomas by carbon dioxide laser. Ann Otol Rhinol Laryngol 2001; 110: 820-826. (Pubitemid 32845727)
35. Hartl DM, de Monès E, Hans S, Janot F, Brasnu D,. Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol 2007; 116: 832-836. (Pubitemid 350174842)
36. Pearson BW, Salassa JR,. Transoral laser microresection for cancer of the larynx involving the anterior commissure. Laryngoscope 2003; 113: 1104-1112. (Pubitemid 36835553)
37. Steiner W, Ambrosch P, Rödel RMW, Kron M,. Impact of anterior commissure involvement of local control of early glottic carcinoma treated by laser microresection. Laryngoscope 2004; 114: 1485-1491. (Pubitemid 39045526)
38. Davis RK, Hadley K, Smith ME,. Endoscopic vertical partial laryngectomy. Laryngoscope 2004; 114: 236-240. (Pubitemid 38182617)
39. Chone CT, Yonehara E, Martins JEF, Altemani A, Crespo AN,. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection. Arch Otolaryngol Head Neck Surg 2007; 133: 882-887. (Pubitemid 47437275)
40. Peretti G, Piazza C, Mensi MC, Magnoni L, Bolzoni A,. Endoscopic treatment of cT2 glottic carcinoma: prognostic impact of different pT subcategories. Ann Otol Rhinol Laryngol 2005; 114: 579-586. (Pubitemid 41170047)
41. Peretti G, Piazza C, Bolzoni A, et al. Analysis of recurrences in 322 Tis, T1, or T2 glottic carcinomas treated by carbon dioxide laser. Ann Otol Rhinol Laryngol 2004; 113: 853-858. (Pubitemid 39488434)
42. Sigston E, de Monès E, Babin E, et al. Early-stage glottic cancer. Oncological results and margins in laser cordectomy. Arch Otolaryngol Head Neck Surg 2006; 132: 147-152. (Pubitemid 43356250)
43. Davis RK,. Endoscopic surgical management of early glottic carcinoma. Otolaryngol Clin North Am 1997; 30: 79-86. (Pubitemid 27087664)
44. Eckel HE, Thumfart WF,. Laser surgery for the treatment of larynx carcinomas: indications, techniques and preliminary results. Ann Otol Rhinol Laryngol 1992; 101: 113-118.
45. Steiner W, Vogt P, Ambrosch P, Kron M,. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy. Head Neck 2004; 26: 477-484. (Pubitemid 38702634)
46. Stoeckli SJ, Schnieper I, Huguenin P, Schmid S,. Early glottic carcinoma: treatment according to patient's preference? Head Neck 2003; 25: 1051-1056. (Pubitemid 37475268)
47. Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW,. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 2001; 19: 4029-4036. (Pubitemid 32976689)
48. Smee RI, Meagher NS, Williams JR, Broadley K, Bridger GP,. Role of radiotherapy in early glottic carcinoma. Head Neck 2009; 32: 850-859.
49. Cellai E, Frata P, Magrini SM, et al. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys 2005; 63: 1378-1386. (Pubitemid 41628032)
50. Jones DA, Mendenhall CM, Kirwan J, et al. Radiation therapy for management of T1-T2 glottic cancer at a private practice. Am J Clin Oncol 2010; Jan 4. [Epub ahead of print].
51. Le QT, Fu KK, Kroll S, et al. Influence of time and fractionation on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997; 39: 1-2.
52. Johansen LV, Overgaard J, Hjelan-Hansen N, et al. Primary radiotherapy for T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys 1990; 18: 1307-1313. (Pubitemid 20234140)
53. Wang CC, Efird JT,. Does prolonged treatment course adversely affect local control of carcinoma of the larynx? Int J Radiat Oncol Biol Phys 1994; 29: 657-660. (Pubitemid 24241303)
54. Mittal B, Rao DV, Marks JE, et al. Role of radiation in the management of early vocal carcinoma. Int J Radiat Oncol Biol Phys 1983; 9: 997-1002. (Pubitemid 13026513)
55. Harwood AR,. Cancer of the larynx. The Toronto experience. J Otolaryngol Suppl 1982; 11: 3-21.
56. Fernberg JO, Ringborg U, Silversward C, et al. Radiation therapy in early glottic cancer. Analysis of 177 consecutive cases. Acta Otolaryngol 1989; 108: 478-481. (Pubitemid 19277466)
57. Sjögren EV, Wiggenraad RG, Le Cessie S, Snijder S, Pomp J, de Jong RJ,. Outcome of radiotherapy in T1 glottic carcinoma: a population-based study. Eur Arch Otorhinolaryngol 2009; 266: 735-744.
58. Dinshaw KA, Sharma V, Agarwal JP, Ghoshi S, Havaldar R,. Radiation therapy in T1-T2 glottic carcinoma: influence of various treatment parameters on local control/complications. Int J Radiat Oncol Biol Phys 2000; 48: 723-735.
59. Groome PA, O'Sullivan B, Mackillop WJ, et al. Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys 2006; 64: 1002-1012.
60. Jin J, Liao ZM, Gao L, Huang XD, Xu GZ,. Analysis of prognostic factors for T1N0M0 glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy of Medical Sciences. Int J Radiat Oncol Biol Phys 2002; 54: 471-478. (Pubitemid 35286814)
61. Howell-Burke D, Peters LJ, Goepfert H, et al. T2 glottic carcinoma: recurrence, salvage, and survival after definitive radiotherapy. Arch Otolaryngol Head Neck Surg 1990; 116: 830-835. (Pubitemid 20218762)
62. Karim ABMF, Kralendonk JH, Yap LY, et al. Heterogeneity of stage II glottic carcinoma and its therapeutic implications. Int J Radiat Oncol Biol Phys 1987; 13: 313-317. (Pubitemid 17053943)
63. Kaplan MJ, Johns ME, McLean WC, et al. Stage II glottic carcinoma: prognostic factors and management. Laryngoscope 1983; 93: 725-728. (Pubitemid 13101619)
64. Mantravadi RVP, Liebner EJ, Haas RE, Skolnik EM, Appelbaum EL,. Cancer of the glottis: prognostic factors in radiation therapy. Radiology 1983; 149: 311-314. (Pubitemid 13006853)
65. Harwood AR, DeBoer G,. Prognostic factors in T2 glottic cancer. Cancer 1980; 45: 991-995. (Pubitemid 10129853)
66. Hendrickson FR,. Radiation therapy treatment of larynx cancers. Cancer 1985; 55: 2058-2061. (Pubitemid 15119168)
67. Dey P, Arnold D, Wight R, McKenzie K, Kelley CG, Wilson J,. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 2002; 2: CD002027.
68. Gourin CG, Conger BT, Sheils C, Bilodeau PA, Coleman TA, Porubsky ES,. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119: 1312-1317.
69. Hartl DM, Brasnu DF,. Chemotherapy alone for glottic carcinoma: a need for higher-level evidence. Ann Otol Rhinol Laryngol 2009; 118: 543-545.
70. Smith JC, Johnson JT, Cognetti DM, et al. Quality of life, functional outcome, and costs of early glottic cancer. Laryngoscope 2003; 113: 68-76. (Pubitemid 36050516)
71. 2 laser or radiotherapy for small T1a glottic carcinomas: costs, local control, survival, quality of life, and voice quality. Head Neck 2007; 29: 128-136. (Pubitemid 46167779)
72. Cragle SP, Brandenburg JH,. Laser cordectomy or radiotherapy: cure rates, communication, and cost. Otolaryngol Head Neck Surg 1993; 108: 648-654. (Pubitemid 23199383)
73. Sjögren EV, van Rossum MA, Langeveld TMP, et al. Voice outcome in T1a midcord glottic carcinoma. Laser surgery vs radiotherapy. Arch Otolaryngol Head Neck Surg 2008; 134: 965-972.
74. Cohen SM, Garrett CG, Dupont WD, Ossoff RH, Courey MS,. Voice-related quality of life in T1 glottic cancer: irradiation versus endoscopic excision. Ann Otol Rhinol Laryngol 2006; 115: 581-586. (Pubitemid 44253503)
75. Wedman J, Heimdal JH, Elstad I, Olofsson J,. Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures. Eur Arch Otorhinolaryngol 2002; 259: 547-550. (Pubitemid 35352116)
76. Peeters AJ, van Gogh CD, Goor KM, Verdonck de Leeuw IM, Langendijk JA, Mahieu HF,. Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol 2004; 261: 534-540.
77. Krengli M, Policarpo M, Manfredda I, et al. Voice quality after treatment for T1a glottic carcinoma-radiotherapy versus laser cordectomy. Acta Oncol 2004; 43: 284-289. (Pubitemid 38757051)
78. Rydell R, Schalen L, Fex S, Elner A,. Voice evaluation before and after laser excision vs. radiotherapy of T1a glottic carcinoma. Acta Otolaryngol 1995; 115: 560-565.
79. 2 laser cordectomy-what can we really expect? Head Neck 2008; 30: 43-49. (Pubitemid 351158320)
80. Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A,. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 2009; 266: 1333-1352.
81. Brandenburg JH,. Laser cordectomy versus radiotherapy: an objective cost analysis. Ann Otol Rhinol Laryngol 2001; 110: 312-318. (Pubitemid 32319798)
82. Nakayama M, Brandeburg JH,. Clinical underestimation of laryngeal cancer. Predictive indicators. Arch Otolaryngol Head Neck Surg 1993; 119: 950-957. (Pubitemid 23270399)
83. Bradley PJ, Rinaldo A, Suárez C, et al. Primary treatment of the anterior vocal commissure squamous carcinoma. Eur Arch Otorhinolaryngol 2006; 263: 879-888. (Pubitemid 44386240)
84. Fernandes R, Gopalan P, Spyridakou C, Joseph G, Kumar M,. Predictive indicators for thyroid cartilage involvement in carcinoma of the larynx seen on spiral computed tomography scans. J Laryngol Otol 2006; 120: 857-860. (Pubitemid 44702036)
85. Becker M,. Neoplastic invasion of laryngeal cartilage: radiologic diagnosis and therapeutic implications. Eur J Radiol 2000; 33: 216-229. (Pubitemid 30107849)
86. Becker M, Zbären P, Casselman JW, Kohler R, Dulguerov P, Becker CD,. Neoplastic invasion of laryngeal cartilage: reassessment of criteria for diagnosis at MR imaging. Radiology 2008; 249: 551-559.
87. Steiner W, Ambrosch P,. Endoscopic laser surgery of the upper aerodigestive tract. New York: Thieme; 2000.
88. Laccourreye O, Muscatello L, Laccourreye L, Naudo P, Brasnu D, Weinstein G,. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for "early" glottic carcinoma classified as T1-T2N0 invading the anterior commissure. Am J Otolaryngol 1997; 18: 385-390. (Pubitemid 27495802)
89. Sachse F, Stool W, Rudack C,. Evaluation of treatment results with regard to initial anterior commissure involvement in early glottic carcinoma treated by external partial surgery or transoral laser microresection. Head Neck 2009; 31: 531-537.
90. Zohar Y, Rahima M, Shvili Y, Talmi YP, Lurie H,. The controversial treatment of anterior commissure carcinoma of the larynx. Laryngoscope 1992; 102: 69-72.
91. Rucci L, Gallo O, Fini-Storchi O,. Glottic cancer involving anterior commissure: surgery vs radiotherapy. Head Neck 1991; 13: 403-410.
92. Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB,. Management of T1-T2 glottic carcinomas. Cancer 2004; 100: 1786-1792. (Pubitemid 38529554)
93. Ferlito A, Silver CE, Howard DJ, Laccourreye O, Rinaldo A, Owen R,. The role of partial laryngeal resection in current management of laryngeal cancer: a collective review. Acta Otolaryngol 2000; 120: 456-465. (Pubitemid 34098291)
94. Frata P, Cellai E, Magrini SM, et al. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. Int J Radiat Oncol Biol Phys 2005; 63: 1387-1394. (Pubitemid 41628033)
95. Burke LS, Greven KM, McGuirt WT, Case D, Hoen HM, Raben M,. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys 1997; 38: 1001-1006. (Pubitemid 27353679)
96. Fein DA, Mendenhall WM, Parsons JT, Million RR,. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys 1993; 25: 605-611. (Pubitemid 23099252)
97. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet JJ,. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol 1997; 106: 364-369. (Pubitemid 27212879)
98. Laccourreye O, Diaz EM Jr, Bassot V, Muscatello L, Garcia D, Brasnu D,. A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis. Cancer 1999; 85: 40-46. (Pubitemid 29031354)
99. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098. (Pubitemid 37464533)
100. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010; 11: 21-28.
101. Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006; 368: 843-854. (Pubitemid 44292807)
102. Matchay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008; 26: 3582-3589.
103. Givens DJ, Karnell LH, Gupta AK, et al. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2009; 135: 1209-1217.
104. Laccourreye O, Salzer SJ, Brasnu D, Shen W, Laccourreye H, Weinstein GS,. Glottic carcinoma with a fixed true vocal cord: outcomes after neoadjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidoepiglottopexy. Otolaryngol Head Neck Surg 1996; 114: 400-406. (Pubitemid 26097128)
105. Wolf GT, Hong WK, Gross Fisher S, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer (The Department of Veterans Affairs [VA] Laryngeal Cancer Study Group). N Engl J Med 1991; 324: 1685-1690.
106. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007; 357: 1705-1715. (Pubitemid 350005152)
107. Pointreau Y, Garaud P, Chapet S, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 2009; 101: 498-506.
108. Pignon JP, Bourhis J, Domenge C, Designé L,. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 255: 949-955. (Pubitemid 30148259)
109. Pignon JP, le Maëtre A, Maillard E, Bourhis J, for the MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009; 92: 4-14.
110. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116 (Suppl 111): 1-13. (Pubitemid 44337830)
111. Chen AY, Halpern M,. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007; 133: 1270-1276. (Pubitemid 350294258)
112. Forastiere AA,. Larynx preservation and survival trends: should there be concern? Head Neck 2010; 32: 14-17.
113. Wolf GT,. Reexamining the treatment of advanced laryngeal cancer: the VA laryngeal cancer study revisited. Head Neck 2010; 32: 7-14.
114. Olsen KD,. Reexamining the treatment of advanced laryngeal cancer. Head Neck 2010; 32: 1-7.
115. Lefebvre JL, Ang KK, for the Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary. Head Neck 2009; 31: 429-441.
116. Forastiere AA, Trotti AM,. Searching for less toxic larynx preservation: a need for common definitions and metrics. J Natl Cancer Inst 2009; 101: 129-131.
117. DeSanto LW, Olsen KD, Perry WC, Rohe DE, Keith RL,. Quality of life after surgical treatment of cancer of the larynx. Ann Otol Rhinol Laryngol 1995; 104: 763-769.
118. Weinstein GS, El-Sawy MM, Ruiz C, et al. Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy. Laryngoscope 2001; 111: 191-199. (Pubitemid 32142822)
119. Fung K, Lyden TH, Lee J, et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 2005; 63: 1395-1399. (Pubitemid 41628034)
120. Clark AL, Lammiman MJ, Goode K, Cleland JG,. Is taking part in clinical trials good for your health? A cohort study. Eur J Heart Fail 2009; 11: 1078-1083.
121. Rachet B, Quinn MJ, Cooper N, Coleman MP,. Survival from cancer of the larynx in England and Wales up to 2001. Br J Cancer 2008; 99: S35-S37.